| Analysis | Metabolite Name | Measured Value | Units | subject type |
|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+ | 9305 | Peak area | Mild disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+ | 11711 | Peak area | Severe disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+ | 12745 | Peak area | Healthy control |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+ | 13374 | Peak area | Mild disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+ | 15125 | Peak area | Mild disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+ | 15599 | Peak area | Healthy control |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+ | 18415 | Peak area | Healthy control |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+ | 20821 | Peak area | Healthy control |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+ | 23698 | Peak area | Mild disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+ | 37155 | Peak area | Severe disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+ | 37230 | Peak area | Severe disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+ | 38108 | Peak area | Severe disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+ | 43048 | Peak area | Healthy control |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+ | 43524 | Peak area | Healthy control |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+ | 47893 | Peak area | Severe disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+ | 48290 | Peak area | Mild disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+ | 60533 | Peak area | Mild disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+ | 107400 | Peak area | Severe disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+[-H2O] | 5419 | Peak area | Mild disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+[-H2O] | 7639 | Peak area | Healthy control |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+[-H2O] | 15887 | Peak area | Severe disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+[-H2O] | 16926 | Peak area | Severe disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+[-H2O] | 18211 | Peak area | Healthy control |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+[-H2O] | 18686 | Peak area | Healthy control |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+[-H2O] | 20456 | Peak area | Mild disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+[-H2O] | 20582 | Peak area | Severe disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+[-H2O] | 25192 | Peak area | Mild disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+[-H2O] | 49235 | Peak area | Severe disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+[-H2O] | Peak area | Healthy control | |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+[-H2O] | Peak area | Mild disease | |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+[-H2O] | Peak area | Severe disease | |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+NA)+ | 75268 | Peak area | Healthy control |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+NA)+ | 75793 | Peak area | Mild disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+NA)+ | 128576 | Peak area | Severe disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+NA)+ | 130006 | Peak area | Severe disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+NA)+ | 133117 | Peak area | Severe disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+NA)+ | 149276 | Peak area | Healthy control |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+NA)+ | 151772 | Peak area | Healthy control |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+NA)+ | 157959 | Peak area | Mild disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+NA)+ | 176359 | Peak area | Severe disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+NA)+ | 213517 | Peak area | Mild disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+NA)+ | 385718 | Peak area | Severe disease |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+NA)+ | Peak area | Healthy control | |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+NA)+ | Peak area | Mild disease | |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+NA)+ | Peak area | Severe disease |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|